A trail of complaints at pharmacy linked to meningitis deaths
Records show that inspectors knew about problems with an injectable steroid produced at the New England Compounding Center going back to 2002. The same tainted drug allegedly to blame for 23 meningitis deaths. Both documents, as well as testimony before a congressional committee, suggest a pattern of violations and modest penalties for the Framingham specialty pharmacy.
- Why Is Healthcare Price Transparency So Hard?
- 5 Hot Healthcare Ideas from SXSW
- EHR Spending Continues, But Jury Still Out on ROI
- Two-Midnights Rule Spells Grim Financial Forecast for Hospitals
- Researchers Link ICD-10 Shift to Financial Losses
- The Trouble with Hospital Price Transparency
- Hospital Groups Strike Back at Hospital Rating Systems
- 4 Marketing Tactics for Hospitals on Instagram
- Adverse Events from Insulin Prescribing 'An Epidemic'
- Hospital CEO Turnover Hits Record High